Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00566878 · ClinicalTrials.gov registry record
Pompe Lactation Sub-Registry
A clinical trial of Pompe Disease and Glycogen Storage Disease, sponsored by Genzyme, a Sanofi Company.
- Completed
- Registry status
- 2
- Enrollment target
- 2
- Study locations
NCT00566878 is a study of Pompe Disease and Glycogen Storage Disease that has completed, run by Genzyme, a Sanofi Company. The registered enrollment target is 2 participants, below the 232-participant average among 14 other Pompe Disease trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00566878, a study of Pompe Disease and Glycogen Storage Disease, has completed, sponsored by Genzyme, a Sanofi Company.
- COMPLETED
- Registry status
- 2 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective is to determine if alglucosidase alfa is present in breast milk from mothers with Pompe Disease being treated with alglucosidase alfa and to measure breast milk production and composition in women with Pompe Disease who receive alglucosidase alfa.
Conditions Studied
Interventions
- BIOLOGICAL alglucosidase alfa
Study Locations (2)
Massachusetts
- Registry participation is worldwide. Facilities not yet active may enroll upon identification of a patient - Cambridge
Michigan
- - Grand Rapids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-03-31 |
| Est. Completion | 2024-02-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00566878
The ClinicalTrials.gov registry entry for NCT00566878 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 232-participant average among 14 other Pompe Disease trials with a reported enrollment target (99% lower). The listed sponsor is Genzyme, a Sanofi Company, which has 196 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pompe Disease appearing as the primary indexed condition, and to 1 intervention - of which alglucosidase alfa is the first listed.
NCT00566878 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Michigan.
Frequently Asked Questions
What is clinical trial NCT00566878 about?
NCT00566878 is a clinical study titled "Pompe Lactation Sub-Registry". The objective is to determine if alglucosidase alfa is present in breast milk from mothers with Pompe Disease being treated with alglucosidase alfa and to measure breast milk production and composition in women with Pompe Disease who receive alglucosidase alfa.
What is the current status of trial NCT00566878?
This trial is currently completed. The enrollment target is 2 participants. The study started on 2012-03-31. Estimated completion is 2024-02-09.
What conditions does trial NCT00566878 study?
This clinical trial studies the following conditions: Pompe Disease, Glycogen Storage Disease.
What interventions are being tested in trial NCT00566878?
The interventions under investigation include: alglucosidase alfa (BIOLOGICAL).
Who is sponsoring clinical trial NCT00566878?
This trial is sponsored by Genzyme, a Sanofi Company, which has 196 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00566878 being conducted?
This trial has 2 study locations across Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pompe Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
RECRUITING · Phase 2
-
Cognitive and Neurological Pathologies in Pompe Disease
RECRUITING
-
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
RECRUITING
-
Pompe Disease Registry Protocol
RECRUITING
-
A Global Prospective Observational Registry of Patients With Pompe Disease
RECRUITING
-
Avalglucosidase Alfa Pregnancy Study
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.